A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients

NCT04950803 NA ACTIVE_NOT_RECRUITING

This study aims to evaluate the effectiveness of an oral microbiome immunity formula in modulating gut microbiota, enhancing immunity and reducing long-term complications and co-morbidities in patients who have recovered from COVID-19.

Details

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	ACTIVE_NOT_RECRUITING
Enrolment	448
Start date	Fri Jun 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• COVID-19
• Probiotic

Interventions

• Microbiome immunity formula
• Active placebo

Countries

Hong Kong